Dr. Schneider Talks to KYW Newsradio about Experimental Drug to Slow Progression of Parkinson’s Disease

Thousands of Americans are diagnosed with Parkinson’s Disease each year. Dr. Jay Schneider, director of the Parkinson’s Disease Research Unit and professor of Pathology, Anatomy and Cell Biology at Thomas Jefferson University found that injecting patients with a chemical normally found in the brain, GM1 ganglioside, was effective in slowing down the progression of the disease.

In a KYW Newsradio interview, Dr. Schneider says, “We saw that there was significant improvement in symptoms in the patients who started using the drug compared to the patients who were on the placebo,” Schneider says. Adding, “Over a 2-1/2 year period, not only did we see an improvement in their symptoms but the progression of their symptoms was so slow that they weren’t even back to where they were at baseline.”

Read the story on CBSLocal.com: “Local Researcher Making Progress In Fight Against Parkinson’s Disease.”

, , , , ,

No comments yet.

Add Your Comments and Join the Conversation

Comments are moderated and generally will be posted if they are on-topic and not abusive.
View our commenting policy.